SENTI-202 targets CD33 or FLT3, sparing EMCN, enhancing precision in treating hematologic malignancies like AML. Preliminary data shows high efficacy, with significant composite complete remission ...

The presentation was featured in the ISCT public announcement, which indicated that the data were "carefully reviewed and selected by the ISCT 2025 Planning Faculty, to explore the latest ...

This was supported by rising demand for data, digital services, and Mobile Money (MoMo), as well as continued investments in network expansion and service innovation. The Chief Executive Officer ...

HAMBURG, Germany--(BUSINESS WIRE)--Topas Therapeutics today announced that it will present clinical Phase 2a data on its lead candidate ... The abstract was selected for presentation in two sessions ...

PRESIDENT DONALD TRUMP has promised to revitalise American manufacturing. His sweeping tariffs are meant to coax firms into reshoring their operations, turning America into an industrial ...

Candel Therapeutics announced an oral presentation of CAN-2409 data at the ASCO Annual Meeting, focusing on prostate cancer treatment. Candel Therapeutics, Inc. announced the acceptance of an ...

Except for the historical information set forth herein, the matters set forth in this press release, including statements regarding the presentation of data from Incyte’s clinical development ...

with a six-minute oral presentation format. It aims at sharing clinical data that stood out among many submissions. The company will also present a poster on randomized Phase II data of TG4001 in ...

Monrovia — The Central Bank of Liberia (CBL) has issued a formal clarification regarding a graphical error in its recently released 2024 Annual Report, stressing ...